Giulia Marvaso
European Institute of Oncology
CancerInternal medicineRadiologyUrologySurgeryMagnetic resonance imagingOncologyRetrospective cohort studyProstateHead and neck cancerAndrogen deprivation therapyConcomitantProstatectomyProstate cancerRadiosurgeryLesionToxicityNuclear medicineRadiation therapyClinical trialMedicine
122Publications
14H-index
567Citations
Publications 127
Newest
#1Piotr Wychowański (Medical University of Warsaw)H-Index: 6
#2Anna Starzyńska (Gdańsk Medical University)H-Index: 7
Last. Barbara Alicja Jereczek-Fossa (IEO: European Institute of Oncology)H-Index: 36
view all 11 authors...
Dental implants are, nowadays, established surgical devices for the restoration of lost teeth. Considered as an alternative for traditional prosthetic appliances, dental implants surpass them in reliability and patient feedback. Local drug delivery around the implants promotes osseointegration and reduces peri-implantitis. However, there are currently no methods of a multiple, precise topical administration of drugs to the implant area. Engineering coatings on the implants, drug application on c...
Source
#1Giulio Francolini (UniFI: University of Florence)H-Index: 13
view all 12 authors...
Postoperative prostate cancer patients are a heterogeneous population, and many prognostic factors (e.g., local staging, PSA kinetics, margin status, histopathological features) may influence their clinical management. In this complex scenario, univocal recommendations are often lacking. For these reasons, the present survey was developed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) to collect the opinion of Italian radiation oncologists and delineate a representation ...
Source
#1Giulio FrancoliniH-Index: 13
#2Luca Eolo Trodella (Università Campus Bio-Medico)H-Index: 7
Last. Paolo BorghettiH-Index: 11
view all 11 authors...
Historically, non-seminomatous germ cell tumor (NSGCT) has been considered a radio-resistant disease, excluding radiotherapy (RT) from curative strategies. However, case series exploring the use of radiation treatment in this setting are often outdated, and prospective ongoing studies testing new radiotherapeutic approaches in NSGCT are lacking. Considering that tremendous advances in radiotherapy technology have enabled improved precision in RT delivery as well as dose escalation while decreasi...
Source
#1Giulia Corrao (IEO: European Institute of Oncology)H-Index: 6
#2Mattia Zaffaroni (IEO: European Institute of Oncology)H-Index: 2
Last. Francesco A. Mistretta (IEO: European Institute of Oncology)H-Index: 14
view all 25 authors...
In recent years, a growing interest has been directed towards oligometastatic prostate cancer (OMPC), as patients with three to five metastatic lesions have shown a significantly better survival as compared with those harboring a higher number of lesions. The efficacy of local ablative treatments directed on metastatic lesions (metastases-directed treatments) was extensively investigated, with the aim of preventing further disease progression and delaying the start of systemic androgen deprivati...
Source
#2Stefano LuzzagoH-Index: 11
Last. Antonio CioffiH-Index: 10
view all 18 authors...
Source
#1Stefano Luzzago (IEO: European Institute of Oncology)H-Index: 11
#2Ottavio De Cobelli (IEO: European Institute of Oncology)H-Index: 31
Last. Gennaro Musi (IEO: European Institute of Oncology)H-Index: 17
view all 18 authors...
BACKGROUND To test clinically significant prostate cancer (csPCa) rates during follow-up in biopsy naive patients that underwent two different diagnostic pathways: (1) SB GROUP (n = 354): systematic random biopsies (SB) vs. (2) TB GROUP (n = 264): multiparametric magnetic resonance imaging (mpMRI) and only targeted biopsies (TB) of PI-RADS ≥ 3 lesions. Patients with PI-RADS ≤ 2 score avoided prostate biopsies. METHODS Retrospective single centre study of 618 biopsy naive patients (2015-2018). Tw...
Source
#1Alberto ColomboH-Index: 1
Last. Giuseppe PetraliaH-Index: 23
view all 10 authors...
We aimed to describe the relationships between the relative fat fraction (%FF), muscle-normalized diffusion-weighted (DW) image signal intensity and water apparent diffusion coefficient (ADC), sex and age for normal bone marrow, in the normal population. Our retrospective cohort consisted of 100 asymptomatic individuals, equally divided by sex and 10-year age groups, who underwent whole-body MRI at 1.5T for early cancer detection. Semi-automated segmentation of global bone marrow volume was perf...
Source
#1Giulia Marvaso (IEO: European Institute of Oncology)H-Index: 14
#2Stefania Volpe (IEO: European Institute of Oncology)H-Index: 9
Last. Barbara Alicja Jereczek-Fossa (IEO: European Institute of Oncology)H-Index: 36
view all 18 authors...
Abstract Context The optimal management of oligometastatic prostate cancer (PCa) is still debated. Objective The purpose of the present systematic review and meta-analysis is to collect the available evidence to date to better define the role of stereotactic body radiotherapy (SBRT) in selected patients with oligorecurrent PCa. Evidence acquisition Study methodology complied with the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA). All prospective studies including PC...
Source
#1Raffaella CambriaH-Index: 16
#2Delia CiardoH-Index: 15
view all 24 authors...
Objective:To compare different stereotactic body techniques—intensity-modulated radiotherapy with photons and protons, applied to radiotherapy of prostatic cancer—with simultaneous integrated boost...
Source
#1Daniela Alterio (IEO: European Institute of Oncology)H-Index: 21
#2Matteo Augugliaro (IEO: European Institute of Oncology)H-Index: 3
Last. Barbara Alicja Jereczek-Fossa (IEO: European Institute of Oncology)H-Index: 36
view all 20 authors...
OBJECTIVE The space comprised between tumor and neck lymph nodes (T-N tract) is one of the main routes of tumor spread in oral cavity tumors. Aim of the study was to investigate the impact of T-N tract involvement on the postoperative radiotherapy (PORT) outcomes. MATERIALS AND METHODS Patients (pts) treated between 2000 and 2016 with indication to PORT were retrospectively retrieved. Inclusion criteria were: 1) locally advanced tumors of the oral cavity, 2) who received with indication to PORT ...
Source